Who is sponsoring NCT04923815?

NCT04923815 is sponsored by Johnson & Johnson Medical (Shanghai) Ltd..

What drugs are being tested in NCT04923815?

Interventions in NCT04923815: THERMOCOOL SMARTTOUCH® Diagnostic/Ablation Deflectable Tip Catheter.

What condition does NCT04923815 study?

NCT04923815 studies AVRT, AVNRT.

Is NCT04923815 still recruiting?

NCT04923815 is currently completed. Last updated 23 February 2022.

Last reviewed 2022-02-23 · How we verify

NCT04923815: ST in PSVT-RWS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Real-world Study of Cardiac Ablation for PSVT Using ST Catheter

Completed Last updated 23 February 2022

What this trial tests

trial testing THERMOCOOL SMARTTOUCH® Diagnostic/Ablation Deflectable Tip Catheter in AVRT, AVNRT in 300 participants. Completed in 14 December 2021.

Timeline

20 July 2021

Primary endpoint
3 December 2021

14 December 2021

Quick facts

Lead sponsor	Johnson & Johnson Medical (Shanghai) Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	20 July 2021
Primary completion	3 December 2021
Estimated completion	14 December 2021
Sites	3 locations across China

Drugs / interventions tested

THERMOCOOL SMARTTOUCH® Diagnostic/Ablation Deflectable Tip Catheter

Conditions studied

AVRT, AVNRT — all drugs for AVRT, AVNRT →

Sponsor

Johnson & Johnson Medical (Shanghai) Ltd. — full company profile →

Who can join

18 and older, any sex, with AVRT, AVNRT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Paroxysmal supraventricular tachycardia known as PSVT includes atrioventricular reentrant tachycardia (AVRT) and atrioventricular nodal reentrant tachycardia (AVNRT). This study is multicenter, retrospective, cohort study. This study will collect real world data of AVNRT and AVRT cohorts retrospectively to evaluate the effectiveness and safety in real world clinical practice. 300 subjects with PSVT will be consecutively enrolled backwards since 02 Nov 2017, and at least 100 subjects for each cohort. Cohort one: AVNRT Cohort two: AVRT, including Wolff-Parkinson-White syndrome（WPW）

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Medical (Shanghai) Ltd. trials

Trials by the same sponsor.

NCT07511166 — A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation · not yet recruiting
NCT07228312 — A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms · not yet recruiting
NCT06510205 — The Study is an Oberservational Post-market Follow-up Program to Evaluate Long Term(5 Years) Safety of Mentor Breast Imp · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04923815 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Medical (Shanghai) Ltd.
Last refreshed: 23 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04923815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing